0001209191-11-032949.txt : 20110603
0001209191-11-032949.hdr.sgml : 20110603
20110603163905
ACCESSION NUMBER: 0001209191-11-032949
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110517
FILED AS OF DATE: 20110603
DATE AS OF CHANGE: 20110603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIOTECH GROWTH N V
CENTRAL INDEX KEY: 0001259869
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-53173
FILM NUMBER: 11892681
MAIL ADDRESS:
STREET 1: DE RUYTERKADE 62 WILLEMSTAD
CITY: CURACO
STATE: P8
ZIP: 000000
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Radius Health, Inc.
CENTRAL INDEX KEY: 0001428522
STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770]
IRS NUMBER: 800145732
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ATTN: CHIEF FINANCIAL OFFICER
STREET 2: 201 BROADWAY, 6TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617 425 9225
MAIL ADDRESS:
STREET 1: ATTN: CHIEF FINANCIAL OFFICER
STREET 2: 201 BROADWAY, 6TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: MPM ACQUISITION CORP
DATE OF NAME CHANGE: 20080228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BB BIOTECH AG
CENTRAL INDEX KEY: 0000924223
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-53173
FILM NUMBER: 11892680
BUSINESS ADDRESS:
STREET 1: VODERGASSE 3
STREET 2: SWITZERLAND
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: CH-8300
BUSINESS PHONE: 411724 59 59
MAIL ADDRESS:
STREET 1: VODERGASSE 3
STREET 2: SWITZERLAND
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: CH-8300
3
1
doc3.xml
FORM 3 SUBMISSION
X0203
3
2011-05-17
0
0001428522
Radius Health, Inc.
NONE
0001259869
BIOTECH GROWTH N V
SNIPWEG 26
CURACAO
P8
00000
NETHERLANDS ANTILLES
0
0
1
0
0000924223
BB BIOTECH AG
VORDERGASSE 3
SCHAFFHAUSEN, SWITZERLAND
V8
8200
SWITZERLAND
0
0
1
0
Series A-1 Convertible Preferred Stock
Common Stock
409400
D
Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Radius Health Inc. held directly or indirectly by Biotech Growth N.V. This Form 3 is filed jointly by BB Biotech and Biotech Growth N.V.
Each share of Series A-1 Convertible Preferred Stock has no expiration date and is convertible at any time, in whole or in part, at the election of the holder at a conversion ratio of 10 shares of Common Stock for every 1 share of Preferred Stock.
/s/ Michael Hutter, Signatory Authority for Biotech Growth N.V. and BB Biotech AG
2011-06-03